Sidewinder Therapeutics
Last verified 2026-06-17. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $90.0Mattributed |
|---|---|
| Latest round | series-b, $60.0M, 2025-08-10attributed |
| Founded | 2022 |
| Headquarters | San Diego |
| Industry | healthcare |
| Stage | series-b+ |
| Website | sidewinderbio.com |
Sidewinder Therapeutics develops bispecific antibody-drug conjugates that target receptor co-complexes on solid tumors. It serves patients with difficult-to-treat solid cancers who need better therapeutic options. By binding two receptors at once, its conjugates aim to improve tumor cell internalization and widen the therapeutic window.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-08-10 | series-b | $60.0M | undisclosed |
Detected tech stack
all in one seo 4.9.5.1, all in one seo pack 4.9.5.1, bugherd, cdnjs, cloudflare, cloudflare bot management, doubleclick floodlight, google analytics, google tag manager, gravity forms 2.9.31, http/3, jquery migrate 3.4.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series B, $60.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $90.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | sidewinderbio.com, read 2026-06-17 |
| Description | self-reported | sidewinderbio.com, read 2026-06-17 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.